Vitronectin receptor antagonist pharmaceuticals for use in...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 51/04 (2006.01) A61K 31/4709 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2412854

The present invention describes novel kits and compositions comprising compounds of the formula (I): (Q)d-Ln-Ch, useful for the diagnosis and treatment of cancer in combination therapy in a patient. The present invention provides novel compounds useful for the treatment of rheumatoid arthritis. The pharmaceuticals are comprised of a targeting moiety that binds to a receptor that is upregulated during angiogenesis, an optional linking group, and a therapeutically effective radioisotope or diagnostically effective imageable moiety.

Cette invention se rapporte à de nouveaux kits et compositions comprenant des composés représentés par la formule (Q)¿d?-L¿n?-C¿h? (I), utiles dans le diagnostic et le traitement du cancer chez des patients suivant une polythérapie. Cette invention propose de nouveaux composés utiles dans le traitement de l'arthrite rhumatoïde. Les agents pharmaceutiques faisant l'objet de cette invention sont constitués par une fraction de ciblage qui se fixe à un récepteur régulé en quantité croissante pendant l'angiogenèse, par un groupe de liaison optionnel et par un radio-isotope efficace à des fins thérapeutiques ou par une fraction visible en imagerie efficace à des fins diagnostiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vitronectin receptor antagonist pharmaceuticals for use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vitronectin receptor antagonist pharmaceuticals for use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitronectin receptor antagonist pharmaceuticals for use in... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1919707

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.